Changes
/* Dolcera Dashboard */
'''This is a landscape report on the Ureteral stent market, including key company profiles, products, patents and relevant clinical trailstrials.
'''
=Patents=
==Patent Search Strategy==
[[Image:Patent Search Strategy.jpg|700px]]
'''Dashboard Link'''<br>
{|border="2" cellspacing="0" cellpadding="4" width="100%"
|'''[httphttps://clientwww.dolcera.com/auth/dashboard/dashboard.htmlphp?workfile_id=1008 Ureteral Stent - Dashboard] '''
|width="100"|[[Image:dashboard_thumb.png|center|100px|]]
|-
= Clinical Trials =
==New trials ==
|}
=Products=
The FDA classifies a ureteric stent as follows:
* TITLE 21 - FOOD AND DRUGS
|-
|}
= Product to Clinical Trial Mapping=
= Product to Patent Mapping =
[[Image:Product_Patent_Mapping_Screen_Shot.png|1000px|centre|thumb|'''Screenshot for the product to patent mapping(Bard and Boston)''']]
* Click [[Media:Product_Patent_Mapping_Bard_Boston.xls|'''Products from Boston Scientific and C R Bard ''']]to download the excel file.
=Patent-Product-Clinical Trial Mapping=
* To access the Dashboard you have to signup. You can do so by clicking [https://www.dolcera.com/auth/index.php/login '''here''']
*''Use the mouse(click and drag/scroll up or down/click on nodes) to explore nodes in the detailed taxonomy''
|}
=Insights=
==IP Activity==
*Patenting activity has been high growth rate during the period 2001 to 2005 with a peak no. of patents in year 2005, followed by saturation during the period 2006 to 2008 and after that a gradual declination upto year 2010 in the ureteral stent research area.
[[Image:IPactivity3.png|thumb|center|1000px|year wise IP activityover the years]]
==Sales ==
Total Sales in 2010 - 4.04 Billion USD
=<span style="color:#C41E3A">Like this report?</span>=
